We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBU icon
2126
Community Bank
CBU
$3.49B
– –
-5,959
Closed -$346K
CBZ icon
2127
CBIZ
CBZ
$2.96B
– –
-5,634
Closed -$378K
CCLD icon
2128
CareCloud
CCLD
$106M
$0 ﹤0.01%
+195
New +$579
CENTA icon
2129
Central Garden & Pet Co Class A
CENTA
$2.41B
– –
-18,080
Closed -$566K
CGBD icon
2130
Carlyle Secured Lending
CGBD
$714M
– –
-61,666
Closed -$1.05M
CGC
2131
Canopy Growth
CGC
$390M
$0 ﹤0.01%
231
+4
+2% +$16
CHRS icon
2132
Coherus Oncology
CHRS
$228M
– –
-883,729
Closed -$919K
CHRW icon
2133
C.H. Robinson
CHRW
$17.9B
– –
-6,636
Closed -$732K
CIM
2134
Chimera Investment
CIM
$984M
– –
-74
Closed -$1K
CINT icon
2135
CI&T Inc
CINT
$454M
$0 ﹤0.01%
+124
New +$835
CIX icon
2136
Comp X International
CIX
$368M
– –
-39
Closed -$1K
CLF icon
2137
Cleveland-Cliffs
CLF
$7.11B
$0 ﹤0.01%
73
– –
CLOV icon
2138
Clover Health Investments
CLOV
$2.24B
– –
-29,720
Closed -$83K
CLSK icon
2139
CleanSpark
CLSK
$3.52B
$0 ﹤0.01%
53
-171
-76% -$2.07K
CLVT icon
2140
Clarivate
CLVT
$1.25B
$0 ﹤0.01%
114
– –
CMT icon
2141
Core Molding Technologies
CMT
$210M
$0 ﹤0.01%
51
-318
-86% -$5.23K
CNXC icon
2142
Concentrix
CNXC
$1.57B
– –
-8,766
Closed -$448K
COCO icon
2143
Vita Coco
COCO
$3.83B
– –
-2,592
Closed -$73K
COOK icon
2144
Traeger
COOK
$189M
$0 ﹤0.01%
+5
New +$767
CRBU icon
2145
Caribou Biosciences
CRBU
$162M
$0 ﹤0.01%
298
– –
CRD.A icon
2146
Crawford & Co Class A
CRD.A
$630M
– –
-1,833
Closed -$20K
CRGX
2147
DELISTED
CARGO Therapeutics
CRGX
$0 ﹤0.01%
32
– –
CRK icon
2148
Comstock Resources
CRK
$3.86B
– –
-1,802
Closed -$20K
CRTO icon
2149
Criteo S.A. Ordinary Shares
CRTO
$845M
– –
-133,694
Closed -$5.38M
CSPI icon
2150
CSP Inc
CSPI
$82.7M
– –
-88
Closed -$1K
84 85
86
87 88

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.